Could Ceramides Become the New Cholesterol?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29307517.
- Also identified by DOI 10.1016/j.cmet.2017.12.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Mayo Clinic recently introduced a diagnostic test that quantifies plasma ceramides in order to identify patients at risk of major adverse cardiac events. By comparing recent discoveries about these biomarker ceramides with the exhaustive body of literature surrounding cholesterol, Summers aims to highlight important advances and critically needed areas of investigation on this exciting class of bioactive lipids.
Medical subject headings
- Ceramides
- Cholesterol